CD8A and non-small cell lung carcinoma: (40) successfully predicted NSCLC patients with high CD8+ T-cell infiltration and PD-1/PD-L1 expression in tumors by constructing a combined model based on clinical features and multiple 18F-FDG PET/CT metabolic features (e.g., SUVmax) (AUC = 0.869).